Tham khảo Chất_gây_ảo_giác_phân_ly

  1. ↑ Tamminga, C. A.; Tanimoto, K.; Kuo, S.; Chase, T. N.; Contreras, P. C.; Rice, K. C.; Jackson, A. E.; O'Donohue, T. L. (1987). “PCP-induced alterations in cerebral glucose utilization in rat brain: Blockade by metaphit, a PCP-receptor-acylating agent”. Synapse. 1 (5): 497–504. doi:10.1002/syn.890010514. PMID 2850626.
  2. ↑ Snyder, Solomon H. (1980). “Phencyclidine”. Nature. 285 (5764): 355–6. doi:10.1038/285355a0. PMID 7189825.
  3. ↑ Giannini, AJ; Eighan, MS; Loiselle, RH; Giannini, MC (1984). “Comparison of haloperidol and chlorpromazine in the treatment of phencyclidine psychosis”. Journal of Clinical Pharmacology. 24 (4): 202–4. doi:10.1002/j.1552-4604.1984.tb01831.x. PMID 6725621.
  4. ↑ Giannini, A. James; Nageotte, Catherine; Loiselle, Robert H.; Malone, Donald A.; Price, William A. (1984). “Comparison of Chlorpromazine, Haloperidol and Pimozide in the Treatment of Phencyclidine Psychosis: Da-2 Receptor Specificity”. Clinical Toxicology. 22 (6): 573–9. doi:10.3109/15563658408992586. PMID 6535849.
  5. 1 2 Pender, John W. (1970). “Dissociative Anesthesia”. California Medicine. 113 (5): 73. PMC 1501800. PMID 18730444.
  6. ↑ Johnstone, M.; Evans, V.; Baigel, S. (1959). “SERNYL (C1−395) IN CLINICAL ANAESTHESIA”. British Journal of Anaesthesia. 31: 433–9. doi:10.1093/bja/31.10.433.
  7. ↑ Oduntan, S. A.; Gool, R. Y. (1970). “Clinical trial of ketamine (ci-581): A preliminary report”. Canadian Anaesthetists' Society Journal. 17: 411–6. doi:10.1007/BF03004705.
  8. ↑ Pender, John W. (tháng 10 năm 1972). “Dissociative Anesthesia”. California Medicine. 117 (4): 46–7. PMC 1518731. PMID 18730832.
  9. ↑ Virtue, RW; Alanis, JM; Mori, M; Lafargue, RT; Vogel, JH; Metcalf, DR (1967). “An anaesthetic agent: 2-orthochlorophenyl, 2-methylamino cyclohexanone HCl (CI-581)”. Anesthesiology. 28 (5): 823–33. doi:10.1097/00000542-196709000-00008. PMID 6035012.
  10. ↑ Mason, Oliver J.; Morgan, Celia J.M.; Stefanovic, Ana; Curran, H Valerie (2008). “The Psychotomimetic States Inventory (PSI): Measuring psychotic-type experiences from ketamine and cannabis”. Schizophrenia Research. 103 (1–3): 138–42. doi:10.1016/j.schres.2008.02.020. PMID 18387788.
  11. ↑ Lim, DK (2003). “Ketamine associated psychedelic effects and dependence” (PDF). Singapore medical journal. 44 (1): 31–4. PMID 12762561.
  12. ↑ Gouzoulis-Mayfrank, E.; Heekeren, K.; Neukirch, A.; Stoll, M.; Stock, C.; Obradovic, M.; Kovar, K.-A. (2005). “Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers”. Pharmacopsychiatry. 38 (6): 301–11. doi:10.1055/s-2005-916185. PMID 16342002.
  13. ↑ Krupitsky, EM; Grinenko, AY (1997). “Ketamine psychedelic therapy (KPT): a review of the results of ten years of research”. Journal of Psychoactive Drugs. 29 (2): 165–83. doi:10.1080/02791072.1997.10400185. PMID 9250944. Bản gốc lưu trữ ngày 19 tháng 8 năm 2010. Truy cập ngày 12 tháng 6 năm 2019.
  14. ↑ Vollenweider, F; Geyer, MA (2001). “A systems model of altered consciousness: integrating natural and drug-induced psychoses”. Brain Research Bulletin. 56 (5): 495–507. doi:10.1016/S0361-9230(01)00646-3. PMID 11750795.
  15. ↑ Gump DW, Ashikaga T, Fink TJ, Radin AM (1977). “Side effects of minocycline: different dosage regimens”. Antimicrob. Agents Chemother. 12 (5): 642–6. doi:10.1128/AAC.12.5.642. PMC 429991. PMID 303498.